Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report
Mohamad A Cherry1, Himanshu Bhardwaj, Sarah Hopps
1Department of Medicine, Hematology Oncology Section, Oklahoma University, OK 73104, USA.
Abstract:
Ifosfamide is an alkylating agent used to treat different types of malignancies including lymphomas, sarcomas and germinal cell tumors. Symptoms of ifosfamide neurotoxicity can range from mild confusion, dizziness and hallucination to overt encephalopathy. Various treatment options like methylene blue, albumin infusion and rarely hemodialysis have been used to treat ifosfamide neurotoxicity. We hereby report a case of a patient with relapsed diffuse large B cell lymphoma who received methylene blue after experiencing acute renal failure and encephalopathy due to ifosfamide with no improvement. The prompt use of hemodialysis in this case has led to reversal of both renal failure and neurotoxicity.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
